DSMB 20% Review Supports Phase 3, Moldova Activated

About this update from Paradigm Biopharmaceuticals Ltd.

Paradigm Biopharmaceuticals Ltd. has released a press release. View Attachment

View stock analysis, news, and events for Paradigm Biopharmaceuticals Ltd.